More than one in five people with multiple sclerosis (MS; 22%) experienced negative changes in their insurance coverage within the past year, and almost one in four patients taking disease-modifying therapy (DMT) relied either partially or completely on discounted or free drug programs (24.7%) for their medications, according to a new study from researchers at the University of Alabama at Birmingham (Neurology 2016 Jun 29. [Epub ahead of print]).
The researchers surveyed a total of 6,662